Introduction 64
The Fallopian tube, also known as oviduct, consists of epithelial and 65 stromal cells forming the mucosal layer, which is surrounded by a layer of 66 smooth muscle cells. The Fallopian tube has several important functions, 67
including transport of gametes for fertilization and transport of the developing 68 embryo to the uterus for implantation. Ectopic pregnancies occur in 69 approximately 2% of all pregnancies (1) , of which about 70% occur in the 70 ampullary region of the tube (2, 3). Tubal ectopic pregnancies (TEP) may 71 lead to complications such as tubal rupture, hemorrhage and maternal 72 mortality. The predisposing factors for TEP were thought to be the impaired 73 transport of the embryo in the Fallopian tube and modifications in the tubal 74 environment favoring tubal implantation (4). Modification of the Fallopian tube 75 environment could be induced by inflammation or modulated by signals from 76 the embryo itself. 77 78 Human chorionic gonadotropin (hCG) is a peptide hormone secreted by 79 the pre-implantation embryo starting from the 8-cell stage (5, 6) . This 80 heterodimeric glycoprotein is structurally similar to luteinizing hormone (LH) 81 and can act as a luteal phase support in assisted reproduction (7) . Both LH 82 and hCG interact with the cell surface luteinizing hormone/chorionic 83 gonadotropin receptor (LHCGR). Recent studies have suggested that hCG 84 may play important roles during embryo implantation by modulating the 85 maternal immune system, down-regulating anti-adhesion molecules, and 86 controlling trophoblast invasion (8-10). However, the mechanisms by which 87 hCG regulates embryo implantation remain largely unknown. 88
Functionally and biologically active LHCGRs are expressed in several 90 tissues, including the female reproductive tract from the Fallopian tubes to the 91 uterus (11-13). However, some studies have reported that hCG can carry out 92 its action independent of LHCGR (14, 15) . LHCGR is a G-protein coupled 93 receptor that is capable of acting through multiple signal transduction 94 pathways, including phospholipid-specific phospholipase C and adenylyl 95 cyclase, which activate the mitogen-activated protein kinase (MAPK) pathway 96 (16, 17). The MAPK pathway contains many components including 97 extracellular signal-regulated kinase (Erk), c-Jun N-terminal kinase (JNKs), 98 and p38. It has been reported that hCG can stimulate production of 99 prostaglandin in endometrial epithelial cells through the phosphatidylinositol 100 3-kinase-extracellular regulatory kinase pathway (18). Recent studies have 101 suggested that Erk can crosstalk and regulate the Wnt/β-catenin signaling 102 pathway, which is essential for implantation (19) (20) (21) . 103
104
In the Wnt/β-catenin signaling pathway, the Wnt ligand binds to the cell 105 surface Frizzled (Fz) receptor, which is a seven-transmembrane domain 106 receptor (22). Interaction between the Wnt ligand and Fz receptor activates 107 Dishevelled (Dvl), which leads to inactivation of glycogen synthase kinase-3β 108 (GSK-3β) (23). GSK-3β is one of the core components of the β-catenin 109 destruction complex, which consists of GSK-3β, phosphorylated adenomatous 110 polyposis coli (APC), and Axin (24). Inactivation of any of the molecules in the 111 β-catenin destruction complex allows β-catenin to escape proteasomal 112 degradation, resulting in cytoplasmic accumulation of β-catenin that can enter 113 the nucleus for gene activation (25). 114
The Wnt/β-catenin signaling pathway has been widely studied and found 116 to be important in normal pregnancy (26, 27) . Activation of the Wnt/β-catenin 117 signaling pathway is essential for embryo adhesion onto the endometrium, 118 trophoblast migration, vascularization, and angiogenesis of the placenta (28). 119
The Wnt/β-catenin signaling pathway has been found to be involved in 120
Fallopian tube inflammation and tubal ectopic pregnancy (29). Wnt activation 121 down-regulated olfactomedin-1 (Olfm1) in oviductal epithelial cells, resulting in 122 a microenvironment which may predispose to TEP (30). Therefore, it is 123 important to understand the regulation and effects of Wnt/β-catenin signaling 124 in implantation to understand tubal ectopic pregnancy. Cytomation) and the nucleus was counter-stained with Hematoxylin. Images 170
were captured under a light microscope with a digital camera (Axioscop, Zeiss,
Göttingen, Germany). The intensity of staining of the epithelial cells in the 172
Fallopian tube sections was quantitated by a single observer using Histological 173 scoring (H-score) in a total of 500 cells in each section (from 4 fields with more 174 than 100 cells in each field) as described previously (30). Results were 175
presented as mean ± SD. Olfm1 and LHCGR proteins were strongly expressed in the cytoplasm of 244 the human Fallopian epithelial cells as detected by immunohistochemistry ( Fig.  245   1A) . Olfm1 expression was significantly lower during the luteal phase of the 246 cycle compared to the follicular and peri-ovulatory phases (Fig. 1B) . In contrast, 247 LHCGR expression in Fallopian tube epithelial cells was significantly higher 248 during the luteal phase compared to the follicular and peri-ovulatory phases 249 Spheroids of about 100 µm in size were prepared for the spheroid 255 attachment assay (Fig. 1C ). OE-E6/E7 or JAr cells were treated with different 256 concentrations of hCG (0, 0.25, 2.5 and 25 IU/mL). OE-E6/E7 cells treated 257 with a concentration of 25 IU/mL hCG significantly increased the attachment 258 rate of non-treated JAr spheroid (P<0.05, Fig. 1Dtop panel) . On the other hand, 259
JAr spheroids treated with different concentrations of hCG before seeding onto 260 the OE-E6/E7 cells untreated with hCG did not show any significant difference 261 in attachment rate (Fig. 1D, middle panel) . OE-E6/E7 cells treated with 2.5 262 and 25 IU/ml hCG had significantly higher attachment rate to JAr cells treated 263 with hCG a fixed concentration of 25 IU/ml (P<0.05, Fig. 1D, bottom panel) . 264 265
Effect of hCG on the expressions of Olfm1 and Wnt/-catenin molecules in OE-E6/E7 and primary Fallopian epithelial cells from tissue 267
OE-E6/E7 cells express hCG receptor, when OE-E6/E7 was treated with 268 hCG (2.5 and 25 IU/mL), there was no effect on hCG receptor, but significantly 269 decreased the Olfm1 expression ( Fig. 2A) . Similarly, hCG (25 IU/mL) 270 down-regulated Olfm1 expression in primary Fallopian epithelial cells isolated 271 from Fallopian tissue (Fig. 2B ). β-catenin was localized at the epithelium of 272 human Fallopian tube and hCG up-regulated active -catenin expression in 273 primary Fallopian epithelial cells isolated from Fallopian tissue (Fig. 2C) . hCG 274 down-regulated Axin2 expression, but increased the ratio of 275 active--catenin/total -catenin expressions in the OE-E6/E7 cells (Fig. 2D) . We found that Olfm1 expression was down-regulated at the ampullary 316 region of the human Fallopian tube at the luteal phase of the cycle. The 317 decreased expression of tubal Olfm1 was in agreement with our previous 318 finding that endometrial Olfm1 was down-regulated in the secretory phase of 319 the cycle (36), when serum progesterone level is high (44). hCG is known to 320 be secreted by trophoblastic cells in human pre-implantation embryo. It has 321 been reported that the trophoblastic JAr cells can secrete 0.1 IU/mL hCG in 24 h (45) and the trophoblastic spheroid can secrete <0.01 IU/mL hCG in 6 days 323 of culture (46). We found that a high hCG level in the local microenvironment 324 favored embryo attachment on epithelial cells in the Fallopian tubes. The 325 upper dosage of hCG (25 IU/mL) used in this experiment was comparable to 326 various studies, which range from 1 to 50 IU/ml (8-10). Assuming that the 327 volume of Fallopian tube to be 1-10 µl, the concentration of hCG encountered 328 by pre-implantation embryo in the blocked tube which could reach 617.5 ~ 61.8 329 IU/ml (9). Results from this study may shed light on the underlying mechanism 330 on the role of hCG in regulating Olfm1 in ectopic pregnancy. 331
332
LHCGR is a G-protein coupled receptor that activates many downstream 333 signaling pathways such as MAPK pathway (16, 17). Accumulating evidence 334 has suggested that the MAPK pathway cross-talks with the Wnt/-catenin 335 signaling pathway through regulation of the -catenin destruction complex, 336 which consists of Axin2, APC and GSK3(47). We previously reported that 337
Wnt-activation down-regulated Olfm1 in Fallopian tube epithelial cells and 338 promoted spheroid attachment (30). To elucidate the molecular mechanism 339 involved in the hCG-mediated attachment process, we examined whether hCG 340 regulated the Wnt/-catenin signaling pathway. We found that -catenin was 341 localized in the epithelial cells of the Fallopian tube and similar expression 342 pattern was reported in mouse oviduct (48). hCG treatment up-regulated 343 active--catenin and down-regulated Axin2 expressions. This suggests that 344
Axin2 down-regulation could allow -catenin to enter the nucleus for the 345 activation of gene transcription (49). Similarly, microarray profiling has also 346 confirmed that Wnt-related genes could be activated by hCG in pre-ovulatory 347 ovarian follicles (50).
349
Our result showed both Erk and Wnt/β-catenin signaling pathways were 350 activated by hCG. However, it was still unknown if the MAPK pathway was 351 upstream or downstream of Wnt/-catenin signaling pathway. Accordingly, we 352 treated OE-E6/E7 cells with either the U0126 Erk inhibitor or the XAV939 Wnt 353 inhibitor to suppress phospho-Erk or Wnt/-catenin signaling pathways, 354 respectively. Interestingly, XAV939 could only inactivate the Wnt/-catenin 355 signaling pathway but not the Erk signaling pathway, which indicated the Erk 356 signaling pathway was likely to be an upstream regulator of Wnt/-catenin 357 signaling pathway in response to hCG treatment (Fig. 4) . 
